D-1051-2017 Class II Terminated

Recalled by Bayer HealthCare Pharmaceuticals, Inc. — Morristown, NJ

FDA drug recall D-1051-2017 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on Mar 30, 2017 and is designated Class II. Reason for recall: Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs. The recall status is terminated (terminated Jan 8, 2020). Affected quantity: 56,064 36-count cartons.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
Mar 30, 2017
Termination Date
Jan 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
56,064 36-count cartons

Product description

Alka-Seltzer Gold (1000 mg Anhydrous citric acid, 344 mg Antacid Potassium bicarbonate, 1050 mg Antacid Sodium bicarbonate/Antacid) Effervescent Tablets, 36-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981, UPC 016500041085

Reason for recall

Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Distribution pattern

Nationwide

Code information

BTAHGR0; Exp. 05/19 BTAHGR1; Exp. 05/19 BTAHGR2; Exp. 05/19 BTAJ0K3; Exp. 07/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1051-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1051-2017. Report a data issue: hello@regdatalab.com.